Vifor Pharma’s DIAMOND trial shows Veltassa enables patients to achieve long-term potassium control
Vifor Pharma, on Monday, announced full results from its phase-IIIb DIAMOND trial showing that Veltassa® allowed patients to achieve long-term potassium control, reduced the risk of…
Read More...
Read More...